Rebecca Racz
Rebecca Racz
Food and Drug Administration
Verified email at
Cited by
Cited by
Updates on the web-based VIOLIN vaccine database and analysis system
Y He, R Racz, S Sayers, Y Lin, T Todd, J Hur, X Li, M Patel, B Zhao, ...
Nucleic acids research 42 (D1), D1124-D1132, 2014
Association between serotonin syndrome and second‐generation antipsychotics via pharmacological target‐adverse event analysis
R Racz, TG Soldatos, D Jackson, K Burkhart
Clinical and translational science 11 (3), 322-329, 2018
Ontology-based collection, representation and analysis of drug-associated neuropathy adverse events
A Guo, R Racz, J Hur, Y Lin, Z Xiang, L Zhao, J Rinder, G Jiang, Q Zhu, ...
Journal of biomedical semantics 7 (1), 1-12, 2016
DNAVaxDB: the first web-based DNA vaccine database and its data analysis
R Racz, X Li, M Patel, Z Xiang, Y He
BMC bioinformatics 15 (4), 1-11, 2014
Systematic annotation and analysis of “virmugens”—Virulence factors whose mutants can be used as live attenuated vaccines
R Racz, M Chung, Z Xiang, Y He
Vaccine 31 (5), 797-805, 2013
Evaluating kratom alkaloids using PHASE
CR Ellis, R Racz, NL Kruhlak, MT Kim, AV Zakharov, N Southall, ...
PloS one 15 (3), e0229646, 2020
Assessing the structural and pharmacological similarity of newly identified drugs of abuse to controlled substances using public health assessment via structural evaluation
CR Ellis, R Racz, NL Kruhlak, MT Kim, EG Hawkins, DG Strauss, ...
Clinical Pharmacology & Therapeutics 106 (1), 116-122, 2019
PathFX provides mechanistic insights into drug efficacy and safety for regulatory review and therapeutic development
JL Wilson, R Racz, T Liu, O Adeniyi, J Sun, A Ramamoorthy, ...
PLoS computational biology 14 (12), e1006614, 2018
Oral acetylcysteine for neuropsychiatric disorders
R Racz, BV Sweet, P Sohoni
American Journal of Health-System Pharmacy 72 (11), 923-929, 2015
Target‐adverse event profiles to augment pharmacovigilance: a pilot study with six new molecular entities
P Schotland, R Racz, D Jackson, R Levin, DG Strauss, K Burkhart
CPT: pharmacometrics & systems pharmacology 7 (12), 809-817, 2018
Target Adverse Event Profiles for Predictive Safety in the Postmarket Setting
P Schotland, R Racz, DB Jackson, TG Soldatos, R Levin, DG Strauss, ...
Clinical Pharmacology & Therapeutics 109 (5), 1232-1243, 2021
Aggregation and analysis of secondary pharmacology data from investigational new drug submissions at the US Food and Drug Administration
A Dodson, K Mi, DP Russo, C Scott, M Saulnier, K Snyder, R Racz
Journal of pharmacological and toxicological methods 111, 107098, 2021
Predicting potential adverse events using safety data from marketed drugs
C Daluwatte, P Schotland, DG Strauss, KK Burkhart, R Racz
BMC bioinformatics 21 (1), 1-21, 2020
Towards precision informatics of pharmacovigilance: OAE-CTCAE mapping and OAE-based representation and analysis of adverse events in patients treated with cancer drugs
MU Wong, R Racz, E Ong, Y He
AMIA Annual Symposium Proceedings 2017, 1793, 2017
Effects of sedative psychotropic drugs combined with oxycodone on respiratory depression in the rat
L Xu, A Krishna, S Stewart, K Shea, R Racz, JL Weaver, DA Volpe, ...
Clinical and Translational Science, 2021
首页 文章 文章详细信息
J Lee, DH Kim, JH Jung, JY Park
Evidence-Based Complementary and Alternative Medicine 2021, 2021
VaximmutorDB: A Web-Based Vaccine Immune Factor Database and Its Application for Understanding Vaccine-Induced Immune Mechanisms
K Berke, P Sun, E Ong, N Sanati, A Huffman, T Brunson, F Loney, ...
Frontiers in immunology 12, 645, 2021
Aggregation and analysis of indication-symptom relationships for drugs approved in the USA
A Punyala, R Lankapalli, D Hindman, R Racz
European journal of clinical pharmacology 76, 1291-1299, 2020
Predicting potential adverse events using safety data from marketed drugs
R Racz
figshare, 2020
Utilization of Informatics Tools to Mechanistically Analyze Drugs Associated with Serotonin Syndrome
R Racz, K Burkhart
The system can't perform the operation now. Try again later.
Articles 1–20